Stock·NYSE·Industrials
Robert Half International Inc (RHI)
- Market cap
- $4.60B
- P/E
- 36.87
- Dividend yield
- 5.25%
- Street target
- $31.00median of 11 analysts
- 52-week range
- $21.83 $47.14
RHI stock forecast today
Where RHI stands today, and what CleaRank Financial AI makes of it.
RHI at a glance
Robert Half International Inc (RHI): Buy, 63/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($38.86 and $31.93).
- Earnings RHI beat estimates in 2 of the 4 reports in our data, and the stock rose the next day every time.
- Insiders Insiders sold $188K and made no open-market purchases over the last 18 months.
- Valuation P/E of 36.9 against 34.0 for the Industrials sector: broadly in line with peers (+8%).
Figures as of October 26, 2026.
CleaRank Financial AI
CleaRank rates Robert Half International Inc (RHI) Buy, with a model score of 63/100.
The trend contributes the most to that score: the price is 40.86% above its 200-day average and 15.76% above its 50-day average, while the 50-day average is 21.69% above the 200-day. The 50-day average is $38.86 and the 200-day is $31.93, and over the past year the price climbed 54.73%.
Only on CleaRank
Figures we compute ourselves from RHI's own price, earnings and insider-filing history. Tap one to see it in context.
RHI stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $44.98 is 15.8% above the 50-day simple moving average of $38.86.Price above its 200-day average ›
The price is 40.9% above the 200-day simple moving average of $31.93.50-day average above the 200-day ›
The 50-day average ($38.86) is 21.7% above the 200-day average ($31.93), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 91% of its 52-week range, between $21.83 and $47.14.
RHI share price
Pick a period: each tab shows how far RHI has moved over it, to the last close.
Today's trading
Where RHI sits inside today's range and its 52-week range.
RHI fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/5P/E below the sector median ›
The trailing P/E of 36.87 is 8.4% above the Industrials median of 34.0.P/S below the sector median ›
The price-to-sales ratio of 0.87 is 78.3% below the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was $121.7M on revenue of $5.3B, a net margin of 2.3%.Beat estimates in most recent reports ›
RHI beat the EPS estimate in 2 of the 4 reports in our data.Pays a dividend ›
The trailing dividend yield is 5.25%, or $2.36 a share a year.
Key statistics
The headline figures for RHI.
As of October 26, 2026, RHI trades at $44.98, with a market value of $4.60B, a P/E ratio of 36.87 and a dividend yield of 5.25%.
What the numbers say
CleaRank Financial AI's reading of RHI's valuation, growth and risks.
RHI trades at 37.60 times trailing earnings, which is 10.6% above the Industrials median of 34.0. The peer comparison on this page calls that P/E broadly in line with peers. On sales, the P/S of 0.87 is 78.3% below the sector median of 4.0. Market value stands at $4.6B, and trailing earnings are $1.22 per share.
Its net margin stands at 2.30% and its operating margin at 5.51%, which shows how much of each sales dollar reaches profit. Return on equity is 10.42%, below the sector median of 17.8%. Debt-to-equity is 0.20, and the trailing dividend yield is 5.25%, equal to $2.36 a share each year.
RHI's latest report, dated October 22, 2026, showed EPS of $0.49 versus an estimate of $0.47. That beat the estimate by 4.26%. Investors responded by pushing the stock up 21.74% in the next session.
The earnings record shows 2 beats in 4 reports, and the stock rose in the first session after each of those beats. Earlier, the stock rose 27.76% after the January 29, 2026 report, a beat of 6.67%. Looking ahead, analysts expect EPS of $1.32 this fiscal year (a decline of 0.9%) and $2.00 the year after (growth of 52.0%).
Daily price moves in RHI average 4.81%, measured as the 30-day standard deviation of daily returns. Its beta against the S&P 500 is 0.83. Insiders sold $188K of stock over the last 18 months and made no open-market purchases. Insider sales are often planned in advance or made to cover tax on vesting shares, so they carry less weight than buying would.
RHI against the Industrials sector
How RHI compares with the median Industrials stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (8% difference), suggesting fair market pricing relative to industry standards.
Return vs XLI: Since May 14, 2025, RHI has lost 5.0% against a gain of 18.8% for XLI.
Performance against XLI
RHI and the Industrials sector fund over the same days.
Revenue and earnings
How much RHI sells, and how much of it becomes profit.
The quarterly bars end with Q2 '26 (the quarter to June 30, 2026); RHI reported again on October 22, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue fell 7.2% in FY2025 to $5.4B, from $5.8B a year earlier.
Profit margin: The net margin was 2.5% in FY2025, down from 4.3% the year before.
Profitable: RHI earned $133M in FY2025.
Earnings reality check
Did RHI beat what analysts expected, and how did the stock react?
Earnings record: RHI beat the analyst estimate in 2 of the 4 reports in our data.
Market reaction: The stock rose in the first session after every beat.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Oct 22, 2026after close | $0.47 | $0.49 | +4.26% | +21.74% | - |
| Jul 23, 2026after close | $0.26 | $0.26 | +0.00% | -6.76% | -1.61% |
| Jan 29, 2026after close | $0.30 | $0.32 | +6.67% | +27.76% | +16.21% |
| Oct 22, 2025after close | $0.43 | $0.43 | +0.00% | -1.25% | -7.39% |
As of October 26, 2026, RHI has beaten the analyst EPS estimate in 2 of the 4 reports in our data and rose in the first trading session after every one of those beats; its latest report, on October 22, 2026, came in 4.26% above the estimate and the stock moved +21.74% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
RHI AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 72.5, in overbought territory.RSI above 50 ›
An RSI of 72.5 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of RHI
The score, the reasoning behind it, and what could move the price next.
RHI is trending higher. The stock sits at $44.98, which is 15.76% above its 50-day average of $38.86 and 40.86% above its 200-day average of $31.93. It is at 91% of its 52-week range, so the price is 4.58% below the 52-week high of $47.14.
Momentum is running hot for RHI. The 14-day RSI sits at 72.5, which is in overbought territory, while the MACD line is positive. Every recent return is a gain: the price is up 13.19% over three months, 72.01% over six months and 54.73% over the year.
Earnings beat ›
The October 22, 2026 report beat the EPS estimate by 4.26%, and the share price rose 21.74% in the first session after it.
Source: Earnings report, October 22, 2026
Rating reaffirmed ›
Goldman Sachs kept its Sell rating on July 24, 2026.
Source: Analyst action, Goldman Sachs, July 24, 2026
- Keep an eye on the two closest levels. Above the price sits the 52-week high at $47.14, and below it sits the 50-day SMA at $38.86.
- With the 14-day RSI at 72.5 and the stock in the overbought zone, alongside a positive MACD line, momentum looks stretched. Readings above 70 or below 30 are the usual markers of that kind of stretch.
- RHI beat estimates in 2 of the 4 reports in our data. After its October 22, 2026 report, the share price climbed 21.74% in the first session.
RHI is holding above its 50-day and 200-day moving averages ($38.86 and $31.93), and that keeps the trend pointing up. A drop through the 50-day would be the first sign of weakness. That average, at $38.86, is the nearest level beneath the current price.
The next level overhead is the 52-week high of $47.14. The RSI is in overbought territory, so a pause would not on its own end the trend. A slide back below the bullish zone would be the sign that momentum is fading.
Technical indicators
Momentum and trend for RHI, from its daily closes.
As of October 26, 2026, with RHI at $44.98, its 14-day RSI is 72.5 (overbought territory), its 50-day simple moving average is $38.86 and its 200-day is $31.93.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What RHI moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, RHI's 1-year correlation of daily returns is +0.27 with S&P 500 (SPY), +0.16 with Nasdaq 100 (QQQ), +0.04 with Bitcoin (BTC) and -0.22 with gold (XAU).
RHI price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
0/3Most analysts rate it a buy ›
4 of 11 analysts rate it a buy or strong buy, 3 a hold and 4 a sell.Median target above the price ›
The median 12-month target of $31.00 is 31.1% below the price.More buy ratings than three months ago ›
4 of 11 rate it a buy now, against 4 of 11 three months ago.
RHI Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jul 24, 2026 | Goldman Sachs | Maintains | Sell |
| Jul 22, 2026 | Truist Securities | Maintains | Buy |
| Jul 14, 2026 | Goldman Sachs | Maintains | Sell |
As of October 26, 2026, 11 Wall Street analysts cover RHI: 4 rate it a buy or strong buy, 3 a hold and 4 a sell or strong sell. Their 12-month price targets range from $20.00 to $50.00. The median RHI price target is $31.00, 31.1% below the price of $44.98.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
RHI trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
RHI trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
RHI moves about 4.8% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much RHI tends to move, against the market and on its own.
RHI price history and drawdowns
RHI's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move under 2% ›
The price has moved 4.81% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 78.9%, from February 2022 to March 2026; the price is still 56.2% below that peak.Most 1-year holds ended higher ›
48% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $16,451, against $42,015 in the S&P 500 (SPY).
RHI Drawdowns & Recovery
As of October 26, 2026, RHI's worst peak-to-trough fall over the last 10 years with dividends reinvested was -78.9% (February 2022 to March 2026); it is still 56.2% below that peak, and 48% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into RHI in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: RHI trailed the S&P 500 over this period: $16,451 against $42,015.
A $10,000 investment in RHI in October 2016 would be worth about $16,451 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to RHI, and which have not.
Strongest month, November: an average of +10.13%, up in 10 of 10 years.
Weakest month, March: an average of -5.40%, up in 2 of 10 years.
This month, October: has averaged -2.48%, up in 5 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, RHI's strongest calendar month has been November (average +10.13%, up in 10 of 10 years) and its weakest March (average -5.40%, up in 2 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
RHI stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in RHI, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in RHI today could grow to about $11,805 by 2030 in the base case, with a 90th-percentile outcome near $29,686 and a 10th-percentile outcome around $4,694. The simulation models price only; at today's 5.25% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
RHI Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $53.10 for RHI by 2030 in the base case, from $44.98 today (1.2x over 4 years). The 10th-percentile path ends near $21.11. These are outcomes of a Monte Carlo simulation run on RHI's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $29.57 | $46.88 | $74.35 | |
| 2028 | $25.46 | $48.87 | $93.81 | |
| 2029 | $22.92 | $50.94 | $113 | |
| 2030 | $21.11 | $53.10 | $134 |
Method: a lognormal simulation of RHI's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
RHI insider trading
What the people running the company have bought and sold.
RHI insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought RHI shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 26, 2026, RHI insiders reported 1 open-market sale worth $188K and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 13, 2026 | Jana Barsten
Director
|
Grant | 10.8K | - |
| May 13, 2026 | Julia Lynn Coronado
Director
|
Grant | 10.8K | - |
| May 13, 2026 | Marc H Morial
Director
|
Grant | 10.8K | - |
| May 13, 2026 | Robert J Pace
Director
|
Grant | 10.8K | - |
| May 13, 2026 | Frederick A Richman
Director
|
Grant | 10.8K | - |
| May 13, 2026 | Marnie Huss Wilking
Director
|
Grant | 10.8K | - |
| Mar 23, 2026 | Michael C Buckley
Chief Financial Officer
|
Grant | 57.3K | - |
| Mar 23, 2026 | Paul F Gentzkow
Officer
|
Grant | 151.2K | - |
| Mar 23, 2026 | Robert W Glass
Officer
|
Grant | 20.6K | - |
| Mar 23, 2026 | Harold M Messmer Jr
Chairman of the Board
|
Grant | 45.0K | - |
| Mar 23, 2026 | Joseph A Tarantino
Officer
|
Grant | 81.3K | - |
| Mar 23, 2026 | Michael Keith Waddell
Chief Executive Officer
|
Grant | 179.8K | - |
| Oct 28, 2025 | Dirk A Kempthorne
Director
|
Sell | 6.5K | $187.8K |
| May 14, 2025 | Jana Barsten
Director
|
Grant | 5.9K | - |
| May 14, 2025 | Julia Lynn Coronado
Director
|
Grant | 5.9K | - |
| May 14, 2025 | Dirk A Kempthorne
Director
|
Grant | 5.9K | - |
| May 14, 2025 | Marc H Morial
Director
|
Grant | 5.9K | - |
| May 14, 2025 | Robert J Pace
Director
|
Grant | 5.9K | - |
| May 14, 2025 | Frederick A Richman
Director
|
Grant | 5.9K | - |
| May 14, 2025 | Marnie Huss Wilking
Director
|
Grant | 5.9K | - |
Source: TwelveData, from SEC Form 4 filings
RHI stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.